Dr. Tse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10021Phone+1 646-227-3813- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1997 - 2000
- Keck School of Medicine of the University of Southern CaliforniaClass of 1997
Certifications & Licensure
- NY State Medical License 2002 - 2025
Clinical Trials
- Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2004 Mar 01
- 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2005 May 01
Publications & Presentations
PubMed
- 5 citationsSTimulator of INterferon Genes Agonism Accelerates Anti-tumor Activity in Poorly Immunogenic Tumors.Samanthi A. Perera, Johnny E. Kopinja, Yanhong Ma, Eric S. Muise, Jason Laskey, Kalyan Chakravarthy, Yiping Chen, Long Cui, Jeremy Presland, Manjiri Sathe, Sarah Javai...> ;Molecular Cancer Therapeutics. 2021 Nov 23
- 6 citationsCharacterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1.Robbie L. McLeod, Minilik Angagaw, Toya Nath Baral, Liming Liu, Raymond J. Moniz, Jason Laskey, SuChun Hsieh, Mike Lee, Jin-Hwan Han, Hassan Issafras, Sarah Javaid, An...> ;Oncotarget. 2018 Oct 2
- 34 citationsPredictive Gene Signatures Determine Tumor Sensitivity to MDM2 InhibitionJo Ishizawa, Kenji Nakamaru, Takahiko Seki, Koichi Tazaki, Kensuke Kojima, Dhruv Chachad, Ran Zhao, Lauren Heese, Wencai Ma, Man Chun John Ma, Courtney D. DiNardo, She...> ;Cancer Research. 2018 May 15
- Join now to see all
Press Mentions
- CStone Presents Research Data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021October 8th, 2021
- CStone Presents Preliminary Results from a Phase Ib Study of the Anti-CTLA-4 Monoclonal Antibody (mAb) CS1002 in Combination with the Anti-PD-1 mAb CS1003 in Patients with Advanced Solid Tumors at ESMO 2021September 19th, 2021
- CStone Received China NMPA IND Approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA Multi-Specific Antibody, Marking Further Expansion of Its Pipeline 2.0September 15th, 2021
- Join now to see all
Grant Support
- Targeting Cell Cycle Checkpoints In Cancer TherapeuticsNational Cancer Institute2006–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: